# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 1.2.6

Extent: E+W+S+N.I.

Tetracyclines
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Chlortetracycline
Sum of parent drug and its 4- epimer
All food-producing species
100 μg/kg
Muscle
300 μg/kg
Liver
600 μg/kg
Kidney
100 μg/kg
Milk
200 μg/kg
Eggs
Doxycycline
Doxycycline
Bovine
100 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption
300 μg/kg
Liver
600 μg/kg
Kidney
Porcine
100 μg/kg
Muscle
300 μg/kg
Skin and fat
300 μg/kg
Liver
600 μg/kg
Kidney
Poultry
100 μg/kg
Muscle
Not for use in animals from which eggs are produced for human consumption
300 μg/kg
Skin and fat
300 μg/kg
Liver
600 μg/kg
Kidney
Oxytetracycline
Sum of parent drug and its 4-epimer
All food-producing species
100 μg/kg
Muscle
300 μg/kg
Liver
600 μg/kg
Kidney
100 μg/kg
Milk
200 μg/kg
Eggs
Tetracycline
Sum of parent drug and its 4-epimer
All food-producing species
100 μg/kg
Muscle
300 μg/kg
Liver
600 μg/kg
Kidney
100 μg/kg
Milk
200 μg/kg
Eggs

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/I/division/1/division/1.2/division/1.2.6 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-I/division-1/division-1.2/division-1.2.6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.